Upper respiratory tract surface areas and volumes of laboratory animals and humans: considerations for dosimetry models.
about
A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadCombination antiviral therapy for influenza: predictions from modeling of human infections.Kinetics of influenza A virus infection in humans.Three-dimensional mapping of ozone-induced injury in the nasal airways of monkeys using magnetic resonance imaging and morphometric techniques.Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.The institutional review board is an impediment to human research: the result is more animal-based research.Contributions of mouse genetic background and age on anterior lens capsule thickness.Manganese tissue dosimetry in rats and monkeys: accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling.Two-generation reproductive toxicity study of inhaled acrylonitrile vapors in Crl:CD(SD) rats.Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.Particle deposition in spontaneously hypertensive rats exposed via whole-body inhalation: measured and estimated dose.Nasal aerodynamics protects brain and lung from inhaled dust in subterranean diggers, Ellobius talpinus.Potential technology for studying dosimetry and response to airborne chemical and biological pollutants.Respiratory tract lung geometry and dosimetry model for male Sprague-Dawley rats.Molecular Binding Contributes to Concentration Dependent Acrolein Deposition in Rat Upper Airways: CFD and Molecular Dynamics Analyses.Size-dependent deposition of inhaled nanoparticles in the rat respiratory tract using a new nose-only exposure system
P2860
Q27324423-667B946B-24D6-45CB-A7D3-29942709F3FAQ28471814-262DCAA9-DE1D-4031-85F8-C348714445ABQ30414648-796A2850-CA63-4672-82C3-9942592ED501Q30445615-B28E295F-693A-469D-A3B5-F4336FEA0B24Q33275732-610BAF1C-AA3F-41D4-AE19-01FB74121706Q34731272-F864A071-2268-460E-8BB5-58B488909F7BQ35081312-FBDF4282-241F-4D94-9319-363E5B4328EBQ37235642-CF57A720-67CF-4E5D-BA9C-328A7A287E50Q46448734-D3A89F0C-16FB-4C3A-87F5-DCCE085ECB2DQ46739134-346446BF-4EF4-4A59-8353-AB09D187661EQ49628598-89C46F80-E508-4DD7-B5A7-01B4D40FD37EQ51164346-804CF6D3-92AF-468C-97D5-3E0ECD452D09Q51416996-7B52E339-852B-4933-AE5F-88F7B80F70F2Q51689736-2C50102E-840D-4F6B-B49D-F9FE9370E990Q51708596-CFA25E8A-C2CC-4031-BCDA-5CF87420C927Q54967886-7CD43CBB-9570-4268-8F18-F71AD9667800Q58096239-9A6A11A5-E502-46A4-9DB5-0B9D2240FCFC
P2860
Upper respiratory tract surface areas and volumes of laboratory animals and humans: considerations for dosimetry models.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Upper respiratory tract surfac ...... erations for dosimetry models.
@en
type
label
Upper respiratory tract surfac ...... erations for dosimetry models.
@en
prefLabel
Upper respiratory tract surfac ...... erations for dosimetry models.
@en
P2093
P2860
P1476
Upper respiratory tract surfac ...... erations for dosimetry models.
@en
P2093
Jarabek AM
Leopold DA
Ménache MG
Zinreich SJ
P2860
P304
P356
10.1080/00984109708984003
P577
1997-04-01T00:00:00Z